Hudson Global to Report Second Quarter 2025 Financial Results on August 8

Stock Information for Lineage Cell Therapeutics, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lineage Cell Therapeutics, Inc.

Hudson Global Renamed Star Equity Holdings, Inc.
Hudson Global Declares Partial Cash Dividend for its 10% Series A Cumulative Perpetual Preferred Stock
Hudson Global and Star Equity Holdings Announce Closing of Merger
Hudson Global Reports 2025 Second Quarter Results
Hudson RPO Announces Strategic Integration of CMRG to Expand Employer Branding and Talent Engagement Capabilities
URGENT: The M&A Class Action Firm Encourages $hareholders to Act Before Vote - Hudson Global, Inc. (HSON) 
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FL, ENZB, HSON on Behalf of Shareholders
SHAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate Merger of FL, ENZB, HSON, and BRZH

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.